Skip to content

Public FDA record

Z-1919-2024: Brand Name: Dako CoverStainer, Dako CoverStainer CPO Product Name: CoverStainer, CoverStainer CPO Model/C

Recall record Z-1919-2024 for Agilent Technologies. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1919-2024
Company in FDA record
Agilent Technologies
FDA classification date
May 29, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is the potential for the front plexiglass door of the automated slide processing system to break causing potential injury.

Source facts

Action
On April 15, 2024, Agilent Technologies, issued a "Urgent Medical Device Correction" notification to affected consignees. Agilent asked consignees to take the following actions: 1. Monitor your device and contact the service organization in case you discover a problem with the plexiglass on the lower front door. - In case the plexiglass of the lower front door is broken, immediately cease operation of the instrument - Do not remove the lower front door assembly, and do not run the instrument without the cover2.Confirm that you have received this information by signing and returning enclosed acknowledgement form Agilent Agilent is currently improving the design of the assembly to correct the issue. When the new design becomes available, the Agilent Service Organization will contact you and update your device at the next service visit. Please document the information on the enclosed Acknowledgement Form and send to Agilent s Field Action Team at fieldactions@agilent.com. In case of any question, please contact your local sales representative or Agilent service organization. We kindly ask you to inform those who need to be aware of this notification within your organization or any other organization to which the affected product(s) have been transferred. Please ensure that your organization maintains awareness of this notice. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Initiated
2024-04-02
Root cause
Device Design
Distribution
Worldwide - US Nationwide distribution in the states of CA, TN, MI, MD, MA, OR, AK, MO, NC, NH, GA, RI and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Hong Kong, Spain, Italy, Japan, Malaysia, Netherland, New Zealand, Norway, Peru, South Korea, Sweden, Switzerland, Taiwan, The United Kingdom, Algeria, Bulgaria, Costa Rica, Cyrpus, Czech Republic, Ecuador, Egypt, Estonia, Greece, Hungary, India, Iraq, Ireland, Isreal, Kenya, Kuwait, Latvia, Lebanon, Morocco, Oman, Poland, Portugal, Qatar, Russia, Saudi Arabia, Slovakia, Thailand, Turkey, Ukraine, United Arab Emirates, Vietnam.
Recall number
Z-1919-2024
Recall status
Open, Classified
CDRH record ID
207331
FDA classified
2024-05-29
Recall event number
94439

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗